Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1

• Published in: Cancer cell international Vol. 20; no. 1; p. 597
• Main Authors: Yarmishyn, Aliaksandr A, Yang, Yi-Ping, Lu, Kai-Hsi, Chen, Yi-Chen, Chien, Yueh, Chou, Shih-Jie, Tsai, Ping-Hsing, Ma, Hsin-I, Chien, Chian-Shiu, Chen, Ming-Teh, Wang, Mong-Lien
• Format: Journal Article
• Language: English
• Published: England BioMed Central 14.12.2020; BMC
• Subjects: Antibodies; Brain cancer; Brain tumors; Cancer progression; Cellulose acetate; Chemoresistance; Chemotherapy; DNA microarrays; Epigenetics; Gene expression; Glioblastoma; Glioblastoma cells; Glioma; Malignancy; Medical prognosis; Morbidity; Musashi protein; Musashi-1; N6-methyladenosine; Phenotypes; Primary Research; Proteins; Reagents; Ribonucleic acid; RNA; RNA modification; Stem cells; Tumors; Up-regulation; YTHDF1; United States > US; Chicago Illinois; Cancer progression; YTHDF1; Musashi-1; Glioblastoma
• ISSN: 1475-2867; 1475-2867
• DOI: 10.1186/s12935-020-01696-9

Glioblastoma (GBM) is the most lethal brain tumor characterized by high morbidity and limited treatment options. Tumor malignancy is usually associated with the epigenetic marks, which coordinate gene expression to ascertain relevant phenotypes. One of such marks is m6A modification of RNA, whose functional effects are dependent on the YTH family m6A reader proteins. In this study, we investigated the expression of five YTH family proteins in different GBM microarray datasets from the Oncomine database, and identified YTHDF1 as the most highly overexpressed member of this family in GBM. By performing the knockdown of YTHDF1 in a GBM cell line, we found that it positively regulates proliferation, chemoresistance and cancer stem cell-like properties. Musashi-1 (MSI1) is a postranscriptional gene expression regulator associated with high oncogenicity in GBM. By knocking down and overexpressing MSI1, we found that it positively regulates YTHDF1 expression. The inhibitory effects imposed on the processes of proliferation and migration by YTHDF1 knockdown were shown to be partially rescued by concomitant overexpression of MSI1. MSI1 and YTHDF1 were shown to be positively correlated in clinical glioma samples, and their concomitant upregulation was associated with decreased survival of glioma patients. We identified the direct regulation of YTHDF1 by MSI1. Given the fact that both proteins are master regulators of gene expression, and both of them are unfavorable factors in GBM, we suggest that in any future studies aimed to uncover the prognostic value and therapy potential, these two proteins should be considered together.